# Ajinomoto Co.

Ajinomoto Co. is an Asset Manager based in Tokyo, Japan.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Tokyo, Japan
- **Region:** Europe
- **Address:** Tokyo, Japan
- **Founded:** 1917
- **Assets under management:** Undisclosed
- **Website:** ajihealthandnutrition.com
- **LinkedIn:** https://www.linkedin.com/company/ajinomoto-health-

## Regulatory record

- **Reports private funds:** No

## About

EMN develops medical food products for patients undergoing surgery and critical illness. The company focuses on nutrition to improve outcomes in these settings.

## Sectors

- Amino Acids
- Animal Nutrition
- Food & Beverage
- Medical Nutrition
- Regenerative Medicine
- Specialty & Personal Care

## Offices

- Itasca, IL, United States
- Kaiseraugst, Switzerland
- Valletta, Malta

## Questions

### How does Ajinomoto Co. monetize amino acid science beyond its legacy food seasonings?

Ajinomoto applies its core fermentation and amino acid production technology across six commercial verticals: amino acids sold as pharmaceutical-grade raw materials, animal nutrition feed-grade supplements, food and beverage ingredient solutions, medical nutrition for chronic conditions, stem cell growth media for regenerative medicine, and specialty chemicals for personal care. The North American subsidiary Ajinomoto Health & Nutrition acts as the B2B channel for pharma, biotech, and food manufacturer ingredients, while subsidiaries like Forge Biologics use amino acid-derived cell culture media to manufacture gene therapies for third-party clients (per the firm, 2024).

### Is Ajinomoto a controlling owner of gene therapy manufacturing capacity?

Yes — through its wholly owned subsidiary Forge Biologics, headquartered in Grove City, Ohio, Ajinomoto operates a contract development and manufacturing organization (CDMO) specializing in adeno-associated virus (AAV) gene therapy production. Forge's 200,000-square-foot facility includes 20 cGMP suites and offers end-to-end plasmid, viral vector, and fill-finish services. Ajinomoto acquired Forge in 2022, converting its position from an amino acid supplier to a controlling stakeholder in cell and gene therapy manufacturing infrastructure (per Ajinomoto Co., 2022).

### What is the relationship between Ajinomoto Health & Nutrition and the publicly traded parent?

Ajinomoto Health & Nutrition North America, Inc. is a wholly owned subsidiary of Ajinomoto Co., Inc., the publicly traded entity on the Tokyo Stock Exchange. Within the North American network, Ajinomoto Health & Nutrition functions as the B2B ingredient, medical nutrition, and bioscience arm — distinct from consumer-facing frozen foods operations run by a separate subsidiary, Ajinomoto Foods North America. This structure segments regulated pharma and biotech supply contracts from branded consumer goods under the same ultimate parent entity (per the firm, 2024).

## Related profiles

- [Blackmount Capital](https://altss.com/profile/blackmount-capital)
- [Maple Park Capital Partners](https://altss.com/profile/maple-park-capital-partners)

---

Last updated: 2026-07-11T16:12:58.000Z

Canonical page: https://altss.com/profile/ajinomoto-co

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology